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Background: The treatment of heart failure (HF) is complex and the prognosis remains serious. A range of
strategies is used across health care systems to improve the quality of care for HF patients. We present results from
a nationwide multidisciplinary initiative to monitor and improve the quality of care and clinical outcome of HF
patients using indicator monitoring combined with systematic auditing.
Methods: We conducted a nationwide, population-based prospective study using data from the Danish Heart
Failure Registry. The registry systematically monitors and audits the use of guideline recommended processes of
care at Danish hospital departments treating incident HF patients. We identified patients registered between 2003
and 2010 (n = 24504) and examined changes in use of recommended processes of care and 1-year mortality.
Results: The use of the majority of the recommended processes of care increased substantially from 2003 to 2010:
echocardiography (from 62.7% to 90.5%; Relative Risk (RR) 1.45 (95% CI, 1.39-1.50)), New York Heart Association
classification (from 29.4% to 85.5%; RR 2.91 (95% CI, 2.69-3.14)), betablockers (from 72.6% to 88.3%; RR 1.23 (95% CI,
1.15-1.29)), physical training (from 5.6% to 22.8%; RR 4.04 (95% CI, 2.96-4.52)), and patient education (from 49.3% to
81.4%; RR 1.65 (95% CI, 1.52-1.80)). Use of ACE/ATII inhibitors remained stable (from 92.0% to 93.2%; RR 1.01 (95% CI,
0.99-1.04)). During the same period, 1-year mortality dropped from 20.5% to 12.8% (adjusted Hazard Ratio 0.79
(95% CI, 0.65-0.96).
Conclusions: Use of guideline recommended processes of care has improved among patients with incident HF
included in the Danish Heart Failure Registry between 2003 and 2010. During the same period, a decrease in
mortality was observed.
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Heart failure (HF) is an important cause of morbidity
and mortality worldwide [1]. The prevalence of HF is
increasing globally due to ageing populations in the de-
veloped countries, improved survival in patients suffer-
ing from coronary events and the success achieved in
postponing coronary events using effective preventive* Correspondence: anne.nakano@stab.rm.dk
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reproduction in any medium, provided the ormeasures [2-8]. HF care has developed substantially in
recent decades and clinical trials have established several
new therapies which have improved clinical outcomes
for patients with HF and reduced left ventricular ejection
fraction (LVEF) [8]. However, treatment guidelines are
adopted slowly and applied inconsistently and may thus
not result in the expected improvements in patient care
and clinical outcomes [9-12]. Consequently, in many
health care systems, major efforts are made to implement
recommended guidelines [13]. However, population-based
data on the implementation of the recommendations in
everyday clinical practice and the possible impact on pa-
tient outcomes are still sparse [14].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dent HF has been monitored and audited continuously
in a national multidisciplinary quality improvement pro-
gram since 2003. We aimed to examine whether the
quality of care and the mortality among incident HF pa-
tients hospitalized in Denmark has changed following
the introduction of the program.
Methods
The Danish heart failure registry
All Danish residents (approximately 5.5 million) have free
access to hospital care provided by the tax-financed
Danish National Health Service. The Danish Heart Failure
Registry (DHFR) was established as a part of a larger na-
tionwide initiative, The Danish National Indicator Project,
in 2003 in order to monitor and improve the quality of
care for HF patients [15].
Since 2003, the DHFR has monitored and supported im-
plementation of evidence-based treatment and care for in-
cident hospitalized HF patients. Participation is mandatory
for all hospital units and outpatient cardiology clinics
treating patients with HF. However, not all hospitals were
able to report to the register when it was launched in 2003.
The prognostic factors recorded in the registry as well
as the evidence-based quality of care indicators were iden-
tified by a multidisciplinary national expert panel based on
national [15] and international guidelines from the Ameri-
can College of Cardiology, the American Heart Associ-
ation [16], and the European Society of Cardiology [17],
supplemented by a systematic literature review. The ex-
pert panel followed a structured, rigorous and evidence-
based guideline-driven process to develop pathways and
tools for clinicians in hospitals and outpatient HF clinics
in order to ensure data accuracy by standardizing proce-
dures. This included developing detailed instructions for
the data collection with strict data definitions ensuringTable 1 Processes of care monitored in the Danish heart failu
Processes of care
Echocardiography Propor
NYHA classification Propor
Medication (ACE/ATII inhibitors) Propor
who is
Medication (Betablockers) Propor
who is
Physical training Propor
referre
Patient education Propor
who st
unders
1-year mortality Propor
or firs
NYHA New York Heart Association, ACEI/ATII Angiotensin Converting Enzyme/Angiothat clinicians register data in the same manner at every
hospital, as well as providing regular performance reports
to the participating hospitals as also done in the American
Heart Association Get With the Guidelines Program for
Heart Failure [18]. The feasibility of collecting the required
data in routine clinical settings, and the ability of the pro-
cesses to reflect the multidisciplinary efforts involved in
modern HF care, were also considered.
The expert panel identified 6 process indicators and 1
outcome indicator (Table 1), and a number of prognostic
factors (Table 2).
Data are registered for HF patients admitted to hos-
pital or at the first outpatient visit as part of the clinical
routine by cardiologists and nursing staff.
The use of 2 processes of care (echocardiography and
New York Heart Association classification (NYHA classifi-
cation) and 1-year mortality is monitored in all patients.
The remaining processes of care (Angiotensin Converting
Enzyme/Angiotensin II antagonist (ACE/ATII) inhibitors,
betablockers, physical training, and patient education) are
only monitored in patients with systolic HF (LVEF ≤ 40%).
Regular, structured audits are conducted on a national,
regional, and local basis, and include validation of the
completeness of patient registration against local hospital
discharge registries and the National Registry of Patients
[19]. Furthermore, every 3 months, the participating de-
partments receive feedback data on their performance
regarding the process indicators as well as unadjusted data
on mortality. The feedback data are reported on a web-
based information system allowing each participating
hospital to review its performance data, and benchmark
them against the region and the whole country.
Study population
The study population included patients with a first time
hospitalization (including in- and out-patients) with HFre registry
tion of patients who undergo echocardiography
tion of patients who undergo NYHA classification
tion of patients with reduced systolic function (LVEF below 40%)
treated with ACE/ATII inhibitors
tion of patients with reduced systolic function (LVEF below 40%)
treated with betablockers
tion of patients with reduced systolic function (LVEF below 40%)
d to individual physical training
tion of patients with reduced systolic function (LVEF below 40%)
arted a structured patient education (inclusive nutrition, physical training,
tanding medical treatment, risk factors and symptoms of the disease)
tion of patients who die within one year of admission to a hospital
t outpatient contact
tensin II Antagonist inhibitors, LVEF Left Ventricular Ejection Fraction.
Table 2 Baseline characteristics among patients
diagnosed with incident heart failure in Denmark
between 2003 and 2010 (N = 24504)
N (%)
Total 24504 (100)
Age mean (SD) 70.8 (13.2)
Gender
Male 15607 (63.7)
Female 8897 (36.3)
Left Ventricular Ejection Fraction (LVEF)
LVEF < 25 6609 (27.0)
25 ≤ LVEF≤ 35 7803 (31.8)
35 < LVEF≤ 40 3498 (14.3)
40 < LVEF < 50 2287 (9.3)
LVEF≥ 50 1134 (4.6)
Missing 3173 (13.6)
New York Heart Association (NYHA) classification
NYHA-class 1 1912 (7.8)
NYHA-class 2 8209 (33.5)
NYHA-class 3 4462 (18.8)
NYHA-class 4 459 (1.9)
Missing 9462 (38.6)
Previous Acute Myocardial Infarction (AMI)
Yes 8046 (32.8)
No 14859 (60.6)
Missing 1599 (6.5)
Stroke
Yes 2561 (10.5)
No 19576 (79.9)
Missing 2367 (9.7)
Chronic Obstructive Pulmonary Disease (COPD)
Yes 3759 (15.3)
No 18480 (75.4)
Missing 2265 (9.2)
In treatment for hypertension
Yes 8335 (34.0)
No 14378 (58.7)
Missing 1791 (7.3)
Diabetes
Yes 4530 (18.5)
No 18362 (74.9)
Missing 1612 (6.6)
Alcohol intake
Maximum 14 drinks for women and 21 for men per week 16683 (68.1)
More than 14 drinks for women and 21 for men per week 1639 (6.7)
Missing 6010 (25.7)
Table 2 Baseline characteristics among patients
diagnosed with incident heart failure in Denmark
between 2003 and 2010 (N = 24504) (Continued)
Smoking habits
Smoker 7101 (29.0)
Non-smoker 17335 (70.8)
Missing 48 (0.2)
SD Standard Deviation, LVEF Left Ventricular Ejection Fraction, NYHA New York
Heart Association, AMI Acute Myocardial Infarction, COPD Chronic Obstructive
Pulmonary Disease.
It was not possible to differentiate between inpatients and outpatients until
2006. Results from 2006 to 2010 are available in the supplementary
online material.
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rienced cardiologist, using the ESC guidelines for defin-
ition of HF, and recorded according to the International
Classification of Diseases, 10th revision (ICD-10) (Codes:
I11.0, I13.0, I13.2, I42.0, I42.6, I42.7, I42.8, I42.9, I50.0,
I50.1, I50.2, I50.3, I50.8, I50.9).
Outpatients had typically previously been admitted to
a cardiology ward with acute myocardial infarction and
had during the admission developed symptoms of HF.
After treatment for the acute myocardial infarction, the
patients were then referred to an outpatient cardiology
clinic for treatment of the HF.
The decision of recording a patient in the registry is
always made by a senior cardiologist to ensure the valid-
ity of the HF diagnosis [7,20]. Each patient was only in-
cluded once in the analyses. Patients were 18 years of
age or older and Danish residents. They were enrolled
irrespective of their left ventricular function. The total
number of patients registered in the DHFR was 24510 in
the study period, but six patients were under 18 years of
age, and therefore excluded, leaving 24504 patients for
analysis.
A total of 41 hospitals and 54 departments were repre-
sented in this study. The hospitals and departments, which
represent all hospitals and departments responsible for
treating HF patients in Denmark, were identified by
Danish Regions, which are responsible for running the
hospitals. For the majority of the departments, the com-
pleteness of the registration of patients was 98-100% in
2010 compared with local hospital discharge registries and
the Danish National Registry of Patients [16].
Data on patient characteristics and mortality
Data on patient characteristics, including gender, age,
comorbidity, left ventricular ejection fraction and NYHA
classification as well as alcohol intake and smoking
habits, were obtained from the DHFR. Information on
vital status (1-year mortality) was obtained from the
Danish Civil Registration System [21], which maintains
electronic records of changes in the vital status of all
residents. Each record carries a unique 10-digit civil
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tion based registries and enables unambiguous linkage
among these registries. The study was approved by the
Danish Data Protection Agency (J.no. 2008-41-2072),
the DHFR, and the Danish Ministry of Health.
Statistics
We computed the proportion of patients receiving
the individual processes of care among those eligible
as well as the proportion of HF patients who died
within 1 year of admission or first contact, both over-
all for the entire study period and according to calen-
dar year (2003–2010). Comparisons over time were
made using binary regression to compute the relative
risk (RR) with 95% confidence intervals (CI) using
2003 as reference. A composite quality of care meas-
ure was also computed for each department. This
measure was defined as the total number of received
processes of care divided by the total number of pro-
cesses of care relevant to the patients admitted to the
individual department.
Analyses on mortality were conducted for the entire
study population and stratified according to LVEF (40% or
less vs. more than 40%). For some patients, data on one or
more of the covariates were missing (Table 2). We used
multiple imputation to impute the missing values assum-
ing that data was missing at random (stata command: ice)
[22-24]. We created 5 datasets based on the following
covariates: age, gender, left ventricular ejection fraction,
previous acute myocardial infarction, stroke, chronic
obstructive pulmonary disease, diabetes, alcohol intake,
smoking habits and patients in treatment for hypertension.
The proportion of patients, for whom data on these vari-
ables were missing, varied between 0.0%-25.7%.
We compared 1-year mortality between patients from
2010 and 2003, respectively using multivariable Cox pro-
portional hazards regression, while controlling for the
patient characteristics presented in Table 2 (except for
NYHA class, due to a high proportion missing data andTable 3 Received processes of care among patients diagnose
and 2010 (N = 24504)
Total Year 2003 to 2010
N (%)
24504 (100)
Processes of care
Echocardiograph performed 19419 (79.5)
NYHA classification assessed 15042 (61.6)
ACE/ATII inhibitors given 12565 (93.0)
Betablockers given 11272 (84.4)
Physical training 2278 (15.9)
Patient education 9852 (70.0)
NYHA New York Heart Association, ACE/ATII Angiotensin Converting Enzyme/Angiotinpatient/outpatient status, which was not registered be-
fore 2006).
Data were analysed using Stata 10.0 (StataCorp LP,
College Station, Texas).
Results
Processes of care
Baseline characteristics of the total patient population
are presented in Table 2. In the Additional file 1: Table
S1, the characteristics are listed according to year of
registration (2003 to 2010). The proportion of patients
receiving the individual processes of care increased sub-
stantially between 2003 and 2010 (Table 3), i.e., use of
echocardiography (RR 1.45, 95% CI, 1.39-1.50), NYHA
classification (RR 2.91, 95% CI, 2.69-3.14) , betablockers
(RR 1.23, 95% CI 1.15-1.29), physical training (RR 4.04,
95% CI, 2.96-5.52) and patient education (RR 1.65, 95%
CI, 1.52-1.80). The only exception was the use of ACE/
ATII inhibitors, where no overall changes were observed
(RR 1.01, 95% CI, 0.99-1.04).
Figure 1 shows the increase in the proportion of pa-
tients who received the recommended processes of care
between 2003 and 2010.
Figure 2 presents the overall composite process indica-
tor, reflecting the proportion of all recommended pro-
cesses of care that was delivered in 2010 at the individual
departments. Although overall improvements were ob-
served for most processes of care, substantial variation in
quality of care remains among hospital departments
treating patients with incident HF in Denmark. The pro-
portion of delivered recommended processes of care var-
ied between 50% and 89% across the departments.
Mortality
Overall 1-year all-cause mortality among patients regis-
tered in the DHFR decreased from 20.5% in 2003 to
12.8% in 2010 (Table 4).
The overall adjusted hazard ratio (HR) for 1-year mor-
tality was 0.79 (95% CI, 0.65-0.96) after multivariabled with incident heart failure in Denmark between 2003
Year 2003 Year 2010 Crude RR
(95% CI)N (%) N (%)
1624 (100) 3809 (100)
1010 (62.7) 3430 (90.5) 1.45 (1.39-1.50)
475 (29.4) 3237 (85.5) 2.91 (2.69-3.14)
446 (92.0) 2628 (93.2) 1.01 (0.99-1.04)
350 (72.6) 2489 (88.3) 1.23 (1.15-1.29)
39 (5.6) 631 (22.8) 4.04 (2.96-5.52)
273 (49.3) 2281 (81.4) 1.65 (1.52-1.80)
ensin II Antagonist inhibitors.
Figure 1 Proportion of patients receiving the recommended processes of care among patients diagnosed with incident heart failure in
Denmark 2003–2010. NYHA classification: New York Heart Association classification, ACE/ATII inhibitors: Angiotensin Converting Enzyme/
Angiotensin II antagonist inhibitor.
Figure 2 Variation between Danish hospital departments in
overall proportion of delivered processes of recommended
care to patients with incident heart failure in 2010. The bars
represent individual hospital departments.
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previous acute myocardial infarction, stroke, chronic ob-
structive pulmonary disease, diabetes, alcohol intake,
smoking habits and in treatment for hypertension), when
comparing patients diagnosed in 2010 with patients di-
agnosed in 2003. Analyses were also stratified for LVEF
(Table 4). The improvements in mortality appeared to
be better in patients with preserved ejection fraction
compared to patients with reduced ejection fraction.
The confidence intervals were, however, overlapping.
Discussion
We found that implementation of indicator monitoring
for HF care in Denmark has been associated with substan-
tial improvements in the use of guideline recommended
processes of care among patients registered in the national
HF registry. Similar results have been observed in at least
two other major quality improvement initiatives: The
Registry to Improve the Use of Evidence-Based Heart Fail-
ure Therapies in the Outpatient Setting (IMPROVE-HF)
for outpatient cardiology practices where 7 quality mea-
sures were assessed and significant improvement achieved
for 5 of the measures. Identical to our study, they did not
reach statistical significance in angiotensin-converting en-
zyme inhibitor/angiotensin receptor blocker [10]. Like-
wise, The Get With the Guidelines Programme for Heart
Failure demonstrated better processes of care as well as
Table 4 One-year mortality among patients diagnosed with incident heart failure in Denmark in 2010 vs. 2003
Mortality 2003 Mortality 2010 Unadjusted HR Adjusted HR * Adjusted HR †
N/total (%) N/total (%) (95% CI) (95% CI) (95% CI)
Total 333/1624 (20.5) 488/3809 (12.8) 0.59 (0.51-0.67) 0.65 (0.56-0.75) 0.79 (0.65-0.96)
LVEF ≤40% 277/1379 (20.1) 408/3141 (13.0) 0.61 (0.52-0.71) 0.67 (0.57-0.78) 0.85 (0.69-1.05)
LVEF >40% 56/245 (22.9) 79/668 (11.8) 0.47 (0.31-0.74) 0.58 (0.40-0.84) 0.51 (0.30-0.89)
*Hazard Ratio (HR) adjusted for age and gender.
† Hazard Ratio (HR) adjusted for the following patient characteristics: age, gender, LVEF, previous acute myocardial infarction, stroke, chronic obstructive
pulmonary disease, diabetes, alcohol intake, smoking habits, and in treatment for hypertension.
LVEF Left Ventricular Ejection Fraction.
Overall and stratified according to selected patient characteristics.
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the guidelines compared to hospitals that did not [18], as
also shown in our study.
Furthermore, we observed a reduced 1-year mortality
rate among Danish HF patients included in the DHFR
when comparing patients diagnosed in 2010 with pa-
tients diagnosed in 2003.
Direct comparisons with other studies is somewhat
hampered by the use of different study designs (popula-
tion-based vs. selected institutions) and patient popula-
tions (prevalent vs. incident patients, inpatients vs.
outpatients). However, the baseline profile of our pa-
tients appears to be comparable with the profile reported
in a number of other studies [10,11,25,26]. Furthermore,
our findings are in general in accordance with and extend
findings from other existing studies, which have addressed
the effects of implementation of clinical guidelines and in-
dicator monitoring. According to two studies by Fonarow
et al. based on data from OPTIMIZE-HF (The Organized
Program to Initiate Lifesaving Treatment in Hospitalized
Patients With Heart Failure) and IMPROVE HF (Primary
results of the Registry to Improve the Use of Evidence-
Based Heart Failure Therapies in the Outpatient Setting
cohort), use of guideline recommended therapies, includ-
ing discharge instructions, assessment of left ventricular
function, ACE inhibitors or angiotensin II receptor bloc-
kers (ARBs) and betablockers at discharge, was associated
with lower mortality [10,27]. There are conflicting results,
though, as Heidenreich et al. found a decrease in the 30-
day readmission rate, but not in the 30-day mortality rate
using data from the American Heart Association’s Get
With The Guidelines Program. The inconsistency may be
related to the studied processes of care and outcomes. The
Get With The Guidelines Program focused on documen-
tation of LVEF, use of ACE inhibitors if LVEF was less than
40%, as well as discharge instructions and smoking cessa-
tion. A stronger association between the processes of care
and short-term mortality could possibly have been found
if the use of betablockers or aldosterone antagonists had
also been assessed since use of these drugs has been
shown to improve survival in randomized trials [18].Our population included both patients with and
without preserved ejection fraction, although it should
be noted that the proportion of included patients
with preserved ejection fraction was quite small (4.6%).
Although we found no statistically significant differ-
ence in the improvements in mortality during the
study period for patients with versus patients without
preserved ejection fraction, we did observe an indica-
tion of a stronger improvement among patients with
preserved ejection fraction. This is noteworthy as the
existing evidence base for treatment of patients with
preserved ejection fraction is weak as no treatment
has yet been shown to reduce morbidity and mortal-
ity in this patient group [17].
Studies on other cardiovascular patient groups, includ-
ing patients with acute coronary syndrome and stroke,
have also provided evidence for the effectiveness of opti-
mizing guideline recommended care among patients en-
countered in real-world clinical practice [28-31]. Our
study appear to add further support to the important
role of clinical guidelines and HF programmes as tools
for bridging the gap between research and routine clin-
ical practice.
In the DHFR, the continuous monitoring of the quality
of care is supplemented by regular audits and public
reporting and release of the performance data from the
individual departments. Such steps may further ensure
commitment and active involvement of the stakeholders,
including clinicians, administrators, patients and politi-
cians. However, challenges remain as demonstrated by
the substantial variation between the hospital depart-
ments in the overall quality of care even after years of
monitoring and auditing.
Strengths and limitations
The strengths of our study include the prospective na-
tionwide population-based design and the large number
of patients included, as well as the fact that registration
is mandatory to all hospitals in Denmark treating pa-
tients with HF, keeping in mind that not all hospitals
were capable of beginning registration at the same time.
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validity in the DNIP. Regular multidisciplinary structu-
red audits are conducted, which include validation of
the completeness of patient registration against hospital
discharge registries and discussion and exchange of ex-
perience and knowledge in order to explain the results
and implement improvements [15].
The main limitation is the observational nature of our
study, which precludes firm conclusions about causality, in
particular with regards to the findings on mortality. The
completeness of the registration of a patient is important in
this context and it should therefore be noted that the num-
ber of patients included in DHFR per year clearly increased
during the study period (from 1624 patients in 2003 to
3809 patients in 2010). This reflected an increasing com-
pleteness of the DHFR as all relevant hospitals and depart-
ments began reporting to the registry at some point
between 2003 and 2010. The DHFR aims to include all in-
cident patients admitted with HF as the primary diagnosis.
Consequently, the DHFR will not reflect the incidence of
HF in the general Danish population. The low proportion
of patients with preserved ejection fraction (4.6%) also indi-
cates that not all hospitalized HF patients were included
since it has been estimated that as many as 20% to 60% of
HF patients have a normal or near normal LVEF [8]. How-
ever, the high completeness of the DHFR compared with
hospital discharge registries, indicates that the registry
probably did cover the vast majority of incident HF patients
admitted to Danish hospitals with HF as the primary diag-
nosis during the study period.
Other factors, besides the nationwide initiative, may
potentially have contributed to the improved quality
of care and lower mortality including a major struc-
tural reform of the Danish health care system in 2007
and a generally increased awareness among clinicians
of guideline recommendations and in particular in-
creased focus on caring for persons with chronic con-
ditions. The latter has during the study period been
specifically stimulated by reports from the National
Board of Health presenting different options for im-
proving care for those with chronic conditions as well
as the publication of disease management programs
for persons with chronic conditions [32,33]. Changes
over time in the prognostic profile of the patients
with incident HF, e.g., the increase in the proportion
of patients being treated as outpatients, is another
important issue. Although we controlled for a range
of well-established prognostic factors in the analyses
on changes in mortality over time, data was not avail-
able on all relevant factors (e.g., creatinine levels and
use of implantable cardioverter defibrillators, cardiac
resynchronization therapy, and aldosterone antagonist
medications). In addition, the proportion of patients
for whom data were missing was substantial for someof the registered variables, e.g., NYHA class (38.6%).
Assuming that our data were missing at random, we used
multiple imputation to account for missing data on the
covariates included in the multivariable analyses on
mortality. This approach is not without pitfalls, in particu-
lar due to the difficulties with assessing whether data are
truly missing at random. However, the implications of
using the technique appeared modest in the analyses, as
all analyses indicated a lower mortality among patients di-
agnosed in 2010 patients compared with patients diag-
nosed in 2003 patients independently on how the available
covariates were included in the multivariable analyses
(data not shown).
Finally, the inherent risk of gaming in top-down initi-
ated quality improvement initiatives such as the DHFR
should not be forgotten. “Gaming” is here understood as
reactive subversion such as “hitting the target and miss-
ing the point” or reducing performance where targets do
not apply. The phenomenon is described by the econo-
mist Charles Goodhart, who following the failure of the
UK government’s reliance on money supply targets in
the 1980s to control inflation, to stated: “Any observed
statistical regularity will tend to collapse once pressure is
placed on it for control purposes’ because actors will
change their conduct when they know that the data they
produce will be used to control them” (Goodhart [34],
p. 96). However, the risk of gaming in the DHFR was prob-
ably quite low due to the regular national, regional and
local multidisciplinary clinical audits, where data collec-
tion and performance was discussed in details. Further-
more, the data validity was also ensured by multiple
audits of medical journals and consistently updated
manuals with explicit instructions to the staff involved
in data collection.
Conclusions
In conclusion, use of guideline recommended processes of
care has improved substantially between 2003 and 2010
following the initiation of systematic quality of care moni-
toring among incident HF patients admitted to Danish
hospitals and registered in the DHFR. The 1-year mortal-
ity appear to have decreased during the same period.
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